|
| |
Steve Tomlin joins Cambridge Healthcare & Biotech as a Principal Associate
CAMBRIDGE, UK, August 25, 2003 - Cambridge Healthcare & Biotech Ltd (CH&B) today
announced that Steve Tomlin had joined the group as a Principal Associate.
Steve Tomlin has over 30 years experience as a senior HR professional, over 25 of them gained
in pharmaceuticals. He joins CH&B from Synavant, where he was HR Director for
International. He has also held senior HR positions with IMS Health, SmithKline Beecham,
Rhône-Poulenc Rorer and Warner-Lambert. Steve’s track record embraces all aspects of the
human and organisational elements of mergers, start-ups and restructuring where he has played
a key role in transitioning and change management in numerous situations both within the UK
and internationally.
Martyn Postle, Director and Founder of CH&B, said. “Steve is particularly valued by us for his
experience in post-acquisition integration and other forms of restructuring. Having Steve on
board allows us to offer our clients a soup to nuts service in M&A, from the initial identification
of a target, through commercial and technical due diligence and to ensuring that post-acquisition
integration is carried out in such a way that the new entity can maximise the benefits of any
synergies and is energised for future growth. Steve is the 22nd Associate to join the CH&B
team. This size of group, especially when complemented by our US alliance partner Back Bay
Strategies, gives us the critical mass to successfully implement major global projects for our
clients.”
Cambridge Healthcare & Biotech
Cambridge Healthcare & Biotech is a knowledge-based consultancy serving all sectors of the
healthcare industry. The company brings a unique perspective to solving client problems
through an in-depth understanding of technology, product development, marketing, healthcare
systems and corporate finance which is embedded in its project teams. In particular, the track
record of its team in commercial and technical due diligence is second to none, enabling its
clients to maximize value and minimize risk in mergers, acquisitions, divestments and licensing
transactions.
ENDS
Contact:
Martyn Postle, Director, Cambridge Healthcare & Biotech
Tel: +44 (0) 1223 839 503
Email: martyn.postle@chandb.com
Cambridge Healthcare & Biotech Ltd, 18 Duxford Road, Whittlesford, Cambridge CB2 4ND
Tel: +44 (0)1223 839 503 Fax (Europe): +44 (0)8701 330 690 or (USA) +1 413 403 6219
http://www.chandb.com e-mail: info@chandb.com
| |
|